Kristin Lowe

Kristin is back at Barnes for her next course of Consolidation Chemotherapy. On Tuesday, at her Clinic Appointment, her initial bloodwork showed that Kristin’s Liver Enzymes were elevated so her Oncologist ordered additional bloodwork and a Liver Ultrasound as a precaution, holding the start of the next HiDAC Chemotherapy Cycle. The ultrasound revealed no abnormalities, and while still above normal, her liver enzymes are consistently dropping. After getting the all clear on her Liver, Kristin received her first round of HiDAC Chemotherapy on Wednesday evening, and has just finished up her second round which started early this morning. She will receive four more rounds before being released sometime on Monday. She is tolerating the chemo very well once again, with extreme fatigue being her main side effect.

Her next Bone Marrow Biopsy has been scheduled for February 4th to determine if the HiDAC Chemotherapy is keeping her in Remission.